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Greater Risk of Decline in Symptomatic Patients With
Left Internal Carotid Artery Disease
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Giorgetta Cappa, MD,* Khenya Strumia, MD,* Paolo Cerrato, MD,†
Federico Ponzio, MD,‡ and Mario Molaschi, MD*
Background: The risk of cognitive decline in patients undergoing carotid endarter-
ectomy (CE) for left internal carotid artery (ICA) (LICA) disease before or after the
occurrence of ischemic symptoms has not been fully elucidated. We evaluated
whether patients undergoing CE for symptomatic LICA stenosis have greater risk
of cognitive decline than patients with asymptomatic LICA disease or right ICA
disease. Methods: In a series of patients aged 65 years and older, consecutively
undergoing CE and free from cognitive impairment, cognitive function was eval-
uated through the age- and education-adjusted Mini Mental State Examination and
the Clock Drawing Task at baseline and at the end of the study period (average
follow-up: 44.4  14.3 months). Results: The analysis included 103 patients (mean
age 72.6  7.0 years; 73 men), of whom 50 had LICA disease (29 symptomatic). At
the end of the study period, Mini Mental State Examination score was reduced in
patients with symptomatic LICA disease (P  .001) but not in other patients,
whereas the Clock Drawing Task score was reduced in both patients with LICA
and right ICA. Patients with symptomatic LICA disease had greater risk of
cognitive decline than other individuals, either measured by the Mini Mental State
Examination score (F  5.18, P  .002) or by the Clock Drawing Task score (F 
9.42, P  .001). Conclusions: Patients undergoing CE for symptomatic LICA disease
appear to be at increased risk of cognitive decline than other individuals. Further
studies are needed to confirm these findings and to evaluate whether LICA
endarterectomy before occurrence of cerebrovascular ischemic symptoms may
provide additive benefit in the prevention of cognitive decline. Key Words:
Elderly—cognitive decline—carotid endarterectomy.
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ournal of Stroke and Cerebrovascular Diseases, Vol. 14, No. 5 (SeptemVascular dementia (VaD) and Alzheimer’s dementia
AD) are the most common causes of dementia among
lderly people.1 Recent basic and clinical investigations
ave provided evidence that AD and VaD, traditionally
onsidered distinct pathophysiologic entities, share sev-
ral common clinical and neuropathologic features,2 and
ome common cerebrovascular risk factors (e.g., hyper-
ension, diabetes, and atrial fibrillation).2,3 Ischemic cere-
rovascular lesions may coexist with typical neurodegen-
rative alterations,2-4 and the presence of ischemic lesions
nhance the cognitive deficit in patients with AD pathol-
gy.5-7 Moreover, there is consistent evidence that pa-
ients who had ischemic cerebrovascular events have a
ber-October), 2005: pp 221-228 221
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M. BO ET AL.222reater risk of developing dementia.8-12 In older individ-
als, mixed dementia is probably more prevalent than
ypical neurodegenerative dementia or VaD.2,3 The defi-
ition of vascular cognitive impairment has been pro-
osed to identify all forms of mild to severe cognitive
mpairment associated with and presumed to be caused
y cerebrovascular disease.13,14
Stenosis of extracranial carotid artery is a well-defined
ause of ischemic cerebrovascular accidents. Although
ome studies have suggested that hemodynamic asymp-
omatic carotid stenosis may be associated with a sub-
tantial risk of cognitive impairment,15,16 the association
etween asymptomatic carotid atherosclerosis and cog-
itive impairment is far from definite.17,18 In a recent
tudy, it was shown that cognitive impairment and de-
line are associated with asymptomatic high-grade steno-
is of the left internal carotid artery (ICA) (LICA), and
hat this association is not a result of underlying risk
actors or atherosclerosis in general.16 This distinction is
mportant because a direct intervention on carotid steno-
is, such as endoarterectomy, might prevent cognitive
ecline. Carotid endarterectomy (CE) has been shown to
e effective in reducing the risk of ischemic events in
ell-defined groups of patients with significant stenosis
f the extracranial carotid artery,19 but its effects on
ognitive function are less well defined.20-26 Specifically,
ne major question that has not been fully elucidated in
revious studies is whether patients undergoing CE for
ymptomatic LICA disease have greater risk of cognitive
ecline than do asymptomatic patients. In that case, there
ight be a potential additive benefit in the prevention of
ognitive decline from CE on LICA before occurrence of
erebrovascular ischemic symptoms. On this back-
round, we hypothesized that patients who undergo CE
or symptomatic LICA stenosis may have greater risk of
ognitive decline than patients who receive CE for
symptomatic LICA stenosis or for right ICA (RICA)
isease, either symptomatic or asymptomatic. Therefore,
n this study we aimed to evaluate whether older patients
ndergoing CE for symptomatic LICA disease experience
reater cognitive decline than those receiving CE for
symptomatic LICA stenosis or for RICA disease.
Methods
Patients 65 years and older eligible to receive CE and
ho were free from dementia or cognitive impairment
ere eligible for the study. Patients were enrolled at the
ay hospital of the vascular surgery department of a
niversity teaching hospital in Turin, Italy. Consecutive
atients admitted to the vascular surgery day hospital
ith a diagnosis of stenosis of the extracranial segment of
he ICA and who were scheduled for CE during the
eriod January through September 1999 were requestedo participate in the study. The following variables were ionsidered: demographics (age, sex); conventional car-
iovascular risk factors (cigarette smoking, diabetes, hy-
ertension, hypercholesterolemia); presence of periph-
ral obstructive arterial disease (ankle-arm index  0.90);
nd history of coronary heart disease (previous myocar-
ial infarction, stable or unstable angina, percutaneous or
urgical coronary revascularization). Hypertension was
efined as a blood pressure of 160/90 mm Hg or greater,
r the use of antihypertensive medications. Diabetes mel-
itus was considered present if a random glucose reading
as 140 mg/dL or greater, a 12-hour fasting glucose
eading was 126 mg/dL or greater, or the participant
ook insulin or oral hypoglycemic drugs. Fasting total
nd high-density lipoprotein cholesterol and triglycer-
des were enzymatically determined, and low-density
ipoprotein cholesterol was calculated according to
riedewald’s formula. According to the Adult Treatment
anel III recommendations for patients with carotid ath-
rosclerosis,27 patients with low-density lipoprotein cho-
esterol greater than 100 mg/dL or nonhigh-density li-
oprotein cholesterol greater than 130 mg/dL, or who
ere treated with lipid-lowering drugs, were considered
ypercholesterolemic. The ankle-arm index was calcu-
ated by a senior physician according to carefully stan-
ardized procedures followed in our noninvasive vascu-
ar diagnostic laboratory.28-30
History of cerebrovascular accidents was investigated
y a senior neurologist through direct interview and
eview of medical charts: transient ischemic attack (TIA)
as defined as an abrupt onset of symptoms and/or
igns related to a focal cerebral or visual deficit attributed
o focal cerebral or retinal ischemia lasting less than 24
ours.31,32 Stroke was defined as an abrupt onset of
ymptoms and/or signs related to a focal and/or global
eficit of cerebral functions lasting more than 24 hours
nd not attributable to causes other than cerebrovascular
ccident.32,33 Reversible ischemic neurologic disorder or
inor stroke was defined as a stroke with no or minimal
mpairment in daily living independence (usually Rankin
core  3).31 According to the medical history of TIA,
troke, and minor stroke, patients were classified as
ymptomatic when they reported at least one cerebrovas-
ular ischemic episode before CE, and asymptomatic
hen they had no history of cerebrovascular symptoms.
nly patients who had their first symptomatic ischemic
pisode in the year preceding CE were included. All
atients underwent cerebral magnetic resonance (MR)
maging (MRI) evaluation before CE; presence and sever-
ty of cerebral ischemic lesions were evaluated by a
ualified neuroradiologist. Infarct on MRI was defined as
n area with abnormal signal intensity in a vascular
istribution, without mass effect.34 Patients without his-
ory of cerebrovascular ischemic symptoms but with MRI
vidence of infarction were excluded. Patients with clin-
cal history of TIA but with MRI evidence of cerebral
nfarction were included among symptomatic patients.
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COGNITIVE DECLINE AND CAROTID ENDARTERECTOMY 223All patients underwent color Doppler ultrasonography
valuation of carotid arteries at the central vascular radi-
logy laboratory of the hospital. Severity of stenosis was
lassified according to the North American Symptomatic
arotid Endarterectomy Trial criteria.35 A further confir-
atory noninvasive imaging test (MR or computed to-
ographic angiography) was performed on selected pa-
ients on clinical judgement of the vascular surgeon.
All patients underwent a baseline evaluation of cogni-
ive performance at the day hospital of our institute,
ollowing a standardized protocol based on clinical eval-
ation, including neurologic history and examination,
nd mental status examination. The cognitive assessment
as performed through the age- and education-adjusted
ini Mental State Examination (MMSE)36 and the Clock
rawing Task (CDT).37 The MMSE36 primarily measures
ognitive function in the dominant cerebral hemi-
phere,38 which is the left hemisphere in more than 98%
f right-handed persons.39 MMSE has been shown to be
reliable instrument for cognitive screening in several
ettings, including the evaluation of cognitive impair-
ent in patients with cerebrovascular disease.38,40,41 The
ange of MMSE score is from 0 to 30; higher scores
ndicate greater cognitive function. The CDT37 evaluates
ultiple areas of cognitive function including compre-
ension, memory, visuospatial abilities, abstract think-
ng, and executive function.37,42,43 Recently, some studies
ave referred the clock-drawing performances to “exec-
tive control” and suggest that CDT may have greater
ensitivity than MMSE in detecting cerebrovascular dis-
ase mainly involving the frontal lobe.44,45 CDT has been
hown to be a reliable screening tool for detecting cogni-
ive impairment in older individuals.43,46-48 The CDT
enerally takes less than 5 minutes to administer and
core. Individuals are verbally instructed to draw a clock,
ut all the numbers in, and set the time at 10 minutes
fter 11. This time is reported to be the most sensitive for
etecting neurocognitive dysfunction.49 Instructions
which are also written at the top of the page) may be
epeated verbatim as needed. No cues are allowed; self-
orrection is permitted. Several scoring scales have been
eveloped for the CDT as a screen for dementia.50-54 The
core proposed by Sunderland et al37 was adopted in the
urrent study: it is based on a set of criteria for evaluating
lock drawings. The score range is from 1 to 10; higher
core indicates better performance. Both MMSE and CDT
ere administered to each patient by the same qualified
eriatrician who was blind to the history of cerebrovas-
ular accidents. Baseline cognitive evaluation was per-
ormed within the month preceding CE in all patients.
atients with AD (diagnosed according to Diagnostic and
tatistical Manual of Mental Disorders, Fourth Edition and
ational Institute of Neurologic Disorders and Stroke-
lzheimer’s Disease and Related Disorders Association
NINCDS-ADRDA] Work Group criteria),55,56 VaD57 or
ith cognitive impairment (MMSE score 25) at baseline pere excluded. The same cognitive evaluation, including
MSE and CDT, was repeated in all survivors at least 3
ears after the surgical procedure, by the same qualified
eriatrician.
Statistical Analysis
Statistical analysis was performed using software
SPSS Version 12.0 packaging for Windows, SPSS). A
escriptive analysis of continuous and categorical vari-
bles was performed. The Chi square test was used to
valuate the association between categorical variables.
he independent samples t test procedure was used to
valuate differences in mean values between groups (it
omputes the differences between values of the two vari-
bles for each case and tests whether the average differs
rom 0). The paired samples t test procedure was used to
valuate differences between two variables within group.
he 1-way analysis of variance procedure for a quantita-
ive variable by a single factor (independent) variable
as used to test the hypothesis that several means are
qual. Once determined the existence of differences
mong means, post hoc pairwise multiple comparisons
Bonferroni) were used to determine which means dif-
ered. Pairwise multiple comparisons test the difference
etween each pair of means and indicate significantly
ifferent group means at an alpha level of 0.05.
Results
During the study period, there were 254 consecutive
atients (age  65 years) eligible for CE. A total of 57
atients were excluded (8 for evidence of cognitive im-
airment at baseline, 13 for MRI evidence of cerebral
nfarction without history of cerebrovascular ischemic
pisodes, and 36 because they resided outside the met-
opolitan area) and 65 refused to participate; 16 patients
id not undergo surgical intervention. In all, 116 patients
ho underwent CE and agreed to participate in the study
ere enrolled and underwent baseline evaluation before
E procedure. A total of 13 patients died during the
eriod of observation. The remaining 103 patients were
onsidered for analysis. In all, 50 patients had LICA
isease (29 symptomatic) and 53 patients had RICA dis-
ase (23 symptomatic). Among symptomatic patients, at
east one TIA was reported by 32 patients (61.5%), a
inor stroke was ascertained in 10 patients (19.2%), and
prior stroke was documented in 19 patients (36.5%).
able 1 reports the main characteristics of the patients
ccording to the side of carotid artery disease and the
resence of ischemic symptoms; no significant differ-
nces were observed between groups. Table 2 shows the
everity of ICA stenosis at baseline and at follow-up
valuation (36.4  4.5 months); bilateral stenosis was
resent in 6 asymptomatic and in 8 symptomatic patients.
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M. BO ET AL.224n the overall sample, restenosis of the operated ICA
ccurred in 10 patients (9.7%).
At the end of the study period, a diagnosis of dementia
as made in 3 patients (2.9% of the overall sample). In
he overall clinical evaluation, some cognitive decline
uring the period of observation (as detected by a signif-
cant reduction in MMSE or CDT score) occurred in 48
Table 1. Main characteri
LICA
symptomatic
n  29
L
asymp
n 
Age, y (mean  SD) 72.9  6.7 72.3
Men/women 21/8 1
Hypertension, n (%) 24 (82.7) 17 (
Hypercholesterolemia, n (%) 19 (65.5) 12 (
Diabetes, n (%) 11 (37.9) 7 (
Smokers, n (%) 20 (69.0) 17 (
CHD, n (%) 12 (41.3) 11 (
POAD, n (%) 10 (34.5) 10 (
AF, n (%) 2 (6.9) 2 (
AF, Atrial fibrillation; CHD, coronary heart disease; LICA, left in
ight internal carotid artery.
Table 2. Severity of internal carotid artery
determined by Do
Asymptomatic
(n  51)
Baseline severity of stenosis:
ICA that underwent CE
50%–70%, n (%) 0 (0)
70%–90%, n (%) 38 (74.5)
90%, n (%) 13 (25.5)
Controlateral ICA
50% 26 (51.1)
50%–70%, n (%) 11 (21.6)
70%–90%, n (%) 11 (21.6)
90%, n (%) 2 (3.9)
Occlusion 1 (2.0)
Follow-up evaluation:
ICA that underwent CE
50% 47 (92.2)
50%–70%, n (%) 1 (2.0)
70%–90%, n (%) 0 (0)
90%, n (%) 2 (3.9)
Occlusion 1 (2.0)
Controlateral ICA
50% 29 (58.0)
50%–70%, n (%) 10 (20.0)
70%–90%, n (%) 8 (16.0)
90%, n (%) 1 (2.0)
Occlusion 2 (4.0)CE, Carotid endoarterectomy; ICA, internal carotid artery.atients (46.6%). Table 3 shows the MMSE and CDT
cores at baseline and at the end of follow-up, according
o the side of carotid artery disease and the presence of
ymptoms. The average time passed from CE to fol-
ow-up evaluation in the overall sample was 44.4  14.3
onths, without differences between groups. No signif-
cant differences were observed at baseline. At the end of
f the patients at baseline
c
RICA
symptomatic
n  23
RICA
asymptomatic
n  30 2 P
72.4  7.2 72.8  8.0
17/6 20/10 0.078 .779
19 (82.6) 25 (83.3) 0.679 .410
14 (60.9) 15 (50.0) 0.100 .752
6 (26.1) 10 (33.3) 0.442 .342
17 (73.9) 22 (73.3) 0.152 .697
7 (30.4) 10 (33.3) 2.231 .135
10 (43.5) 11 (36.6) 1.659 .198
2 (8.7) 2 (6.6) 0.115 .734
arotid study; POAD, peripheral obstructive arterial disease; RICA,
is at baseline and at follow-up evaluation,
ultrasonography
Symptomatic
(n  52)
4 (7.7)
32 (61.5)
16 (30.8) t  4.815 P  .090
36 (69.2)
7 (13.5)
4 (7.7)
0 (0)
5 (9.6) t  10.490 P  .062
46 (88.5)
1 (2.0)
2 (3.8)
3 (5.8)
0 (0) t  4.292 P  .508
32 (62.2)
9 (17.6)
5 (9.8)
0 (0)
5 (9.8) t  3.825 P  .575stics o
ICA
tomati
21
 6.1
5/6
80.9)
57.1)
33.3)
80.9)
52.4)
47.6)
9.5)
ternal cstenos
ppler
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COGNITIVE DECLINE AND CAROTID ENDARTERECTOMY 225he study period, MMSE score was significantly reduced
or patients with symptomatic LICA disease (t  7.001, P
.001) but it was not for patients with asymptomatic
ICA or for those with RICA disease. Overall, patients
ith symptomatic LICA disease had greater cognitive
ecline as measured by the MMSE score than other
ndividuals (F  5.18, P  .002), most of this difference
eing accounted for by greater decline compared with
atients with asymptomatic LICA and RICA (P  .05
oth). At the end of the study period, a significant reduc-
ion in CDT score was observed in each group. Patients
ho underwent CE for symptomatic LICA disease had
reater cognitive decline as measured by the CDT score
han other individuals (F  9.42, P  .001), with signifi-
ant differences between patients with symptomatic
ICA and each other group of patients.
Discussion
The results of this study show that, in a period of 44
onths, some cognitive decline occurred in roughly half
f patients who underwent CE, and dementia developed
n 3% of these patients. Patients who received CE for
ymptomatic LICA disease had significantly greater risk
f cognitive decline, determined either by the age- and
ducation-adjusted MMSE or by the CDT, than patients
perated on for asymptomatic LICA disease or for RICA
Table 3. Mini Mental State Examination and Clock Draw
according to the side of carotid
CDT, Clock drawing task; LICA, left internal carotid artery; M
nternal carotid artery.
*Bonferroni test.
†One-way analysis of variance.isease, either symptomatic or asymptomatic. Silent ce cebral ischemia, and clinically evident cerebrovascular
schemic events, may be a cause of cognitive decline in
lder patients.8,12,32,58,59 The presence of high-grade ste-
osis of the ICA is associated with silent cerebral infarc-
ion and symptomatic infarction.60 Cerebrovascular isch-
mic episodes involving the left hemisphere, and
symptomatic high-grade stenosis of the LICA, are asso-
iated with increased risk of cognitive impairment.8-12,16
lthough a direct relation between cerebrovascular isch-
mic symptoms and silent cerebrovascular ischemia has
ot been stated, it is reasonable to argue that patients
ith cerebrovascular ischemic symptoms may have a
reater burden of cerebral ischemic than asymptomatic
ndividuals and, therefore, a greater risk of cognitive
ecline. Our findings confirm this hypothesis and dem-
nstrate that among patients undergoing CE, those with
ymptomatic LICA stenosis have greater risk of cognitive
ecline than asymptomatic patients with LICA disease or
atients with RICA disease, either symptomatic or
symptomatic. Therefore, our results suggest that pa-
ients with LICA disease might derive some additive
enefit in the prevention of cognitive decline from end-
rterectomy before occurrence of cerebrovascular isch-
mic symptoms. However, specifically designed larger
tudies are needed to confirm these findings, before the
hreshold for endarterectomy or carotid stenting may
ask score at baseline and at the end of the study period,
and the presence of symptoms
P  .05*
P  .05*
P  .05*
F  5.18†
P  .002†
P  .05*P  .05*
F  9.42†
P  .001†P  .05
Mini Mental State Examination; NS, not significant; RICA, righting T
disease
MSE,hange.
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M. BO ET AL.226Observational studies have suggested that cognitive
unction improves in some patients after endoarterec-
omy, but other studies show conflicting results.20-26
owever, in most of these studies, differences between
tenosis of the RICA and LICA, and between symptom-
tic and asymptomatic patients, were not evaluated. On
his background, our findings indicate that nearly half of
atients who undergo CE experience some cognitive de-
line, and that this risk is significantly increased in symp-
omatic patients with LICA disease. Previous studies
emonstrated that, in a 5-year follow-up, 50% of asymp-
omatic individuals with unoperated high-grade stenosis
f the LICA had cognitive decline.16 Although a direct
omparison between different studies is not feasible, our
ndings would suggest that CE might provide some
rotection against cognitive decline in these patients.
eduction in risk for cognitive decline might be an im-
ortant additive benefit of surgical interventions to treat
arotid artery disease. However, further study is war-
anted before considering CE in patients without history
f cerebrovascular ischemic events.
Although both MMSE and CDT consistently detected a
reater risk of cognitive decline in patients with symp-
omatic LICA than in other individuals, the CDT ap-
eared more sensitive in revealing cognitive impairment
mong patients with cerebrovascular disease. The CDT
as been used to evaluate mainly frontal functions and,
articularly, visuospatial abilities in patients with
D.37,42,43 Recently, some studies referred the clock-
rawing performances to executive control and sug-
ested that CDT may have greater sensitivity than MMSE
n detecting cerebrovascular disease mainly involving the
rontal lobe.44,45 Although the predictive value of im-
aired performances in CDT has not been defined, our
esults show that CDT is extremely sensitive in recogniz-
ng cognitive impairment in patients who undergo oper-
tion for high-grade carotid stenosis. These findings add
upport to current evidence that CDT might be a useful
ool for detecting an impairment in frontal executive
unctions, which is a hallmark of vascular cognitive im-
airment.61-63
Some limitations of this study should be addressed. In
ur view, the main limitation is probably represented by
he relatively small sample, which may have underpow-
red our study to detect further significant differences
etween groups and may limit the generalization of
esults; current implementation of the sample size inves-
igated may add further information. We decided to
nclude only consecutive patients aged 65 years and
lder; this decision stems from the consideration that
lder patients are the most prevalent among candidates
o CE and, at the same time, they have far greater risk of
ognitive decline than younger patients. The symptom-
tic group was composed of patients with a varying
linical background; although a further distinction (e.g.,
troke v TIA) might provide a better opinion, this wouldave required a greater sample size to detect clinical
ifferences. Moreover, this further distinction should not
ave affected the validity of current results, which sug-
est an increased incidence of cognitive decline in symp-
omatic patients with LICA disease. Finally, it might be
rgued that symptomatic patients have increased risk of
ognitive decline compared with asymptomatic patients
rrespective of whether patients received CE or not and
hat, therefore, the study would require a control group
onsisting of patients without operation. However, the
nclusion of a control group with significant carotid dis-
ase, although asymptomatic, excluded from the surgical
ption, would not be ethically feasible. Moreover, it
ould not add to the question addressed in the current
tudy, which is not whether CE is associated with cogni-
ive decline, but whether CE performed before symptoms
n patients with LICA disease may have potential benefit
n the prevention of cognitive decline.
In conclusion, our results demonstrate that in a sample
f older patients undergoing CE, those who have symp-
omatic LICA disease have increased risk of cognitive
ecline. Therefore, it can be inferred that patients with
ICA disease might derive some additive benefit in the
revention of cognitive decline from endarterectomy be-
ore occurrence of cerebrovascular ischemic symptoms.
owever, specifically designed larger studies are needed
o confirm these findings, before the threshold for endar-
erectomy or carotid stenting may change.
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